CMM Seminar Series: The role of glial cells in rare inherited brain disorders by Dr. Thomas Durcan
- Time:
- Location:
- CMM Lecture Hall, Visionsgatan 18, floor 00, Karolinska University Hospital, Solna, L8:00.
- Speaker:
- Dr Thomas Durcan, Department of Neurology and Neurosurgery at McGill University, Montreal, Canada.
- Topic:
- The role of glial cells in rare inherited brain disorders
Speaker: Dr Thomas Durcan, Department of Neurology and Neurosurgery at McGill University, Montreal, Canada.
Title of the talk: The role of glial cells in rare inherited brain disorders
Date and time: Wednesday 28 October 2026, 15:00-16:00, followed by a networking reception.
Host: Associate Professor Ida Nilsson.
Venue: CMM Lecture Hall, Visionsgatan 18, floor 00, Karolinska University Hospital, Solna, L8:00.
After the talk there will be a networking reception with some drinks and light bites.
Thank you for signing up using this link or using the QR code. It facilitates the organization!
Speaker’s short bio:
Dr. Thomas M. Durcan is an Associate Professor within the Montreal Neurological Institute (The Neuro) and McGill University and Director of the Neuro’s Early Drug Discovery Unit (EDDU), focused on the use of human induced pluripotent stem cells (iPSCs) for fundamental and translational discovery project through partnerships with academia and industry. Founded under a decade ago, the group has established a cohort of 200+ iPSCs that have been advanced into both discovery and translational projects and used to generate a wide range of neuronal and glial subtypes, in addition to more advanced 3D brain organoid models, with a focus on Parkinson’s disease, ALS and rare diseases. Working with others, through these models advancements in RNA and precision therapies are advancing within the EDDU.